Image de couverture de livre

Deep medullary vein abnormalities associated with cognitive function and Alzheimer's disease plasma biomarkers in dementia‐free older adults: A population‐based study

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Dejia Yin, Jiafeng Wang, Chunyan Li, Xiaoyu Wang, Yan Wang, Qianqian Xie, Na Tian, Ziwei Chen, Xuemin Sun, Yongxiang Wang, Tingting Hou, Lin Cong, Li Zhou, Yifeng Du, Lin Song, Chengxuan Qiu
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Association of enlarged perivascular spaces with cognitive function in dementia‐free older adults: A population‐based study
par: Mingqing Zhao, et autres
Publié: (2024)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
par: Sofia Toniolo, et autres
Publié: (2024)

Reduced plasma hexosylceramides in frontotemporal dementia are a biomarker of white matter integrity
par: Oana C. Marian, et autres
Publié: (2025)

Neurology and inflammatory‐associated plasma protein biomarkers linked to dementia progression, brain aging pathology
par: Noah Schweitzer, et autres
Publié: (2026)

Plasma biomarker‐informed brain topology for cognitive resilience: applications in non‐pharmacological interventions concerning cognitive aging
par: Meishan Ai, et autres
Publié: (2026)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
par: Ihab Hajjar, et autres
Publié: (2024)

Establishment and verification of reference intervals for Alzheimer's disease plasma biomarkers based on evaluation of pre‐analytical procedures: a multicenter study
par: Wencan Jiang, et autres
Publié: (2025)

Genetic associations of plasma proteomics with dementia subtypes and neuroimaging markers
par: Ahmed M. Salih, et autres
Publié: (2025)

Associations of abdominal adiposity, lean body mass, and fat body mass with dementia and cognitive change in older age
par: Zimu Wu, et autres
Publié: (2025)

Cardiometabolic disease, cognitive decline, and brain structure in middle and older age
par: Abigail Dove, et autres
Publié: (2024)

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
par: Adam H. Dyer, et autres
Publié: (2025)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
par: Marieclaire Overton, et autres
Publié: (2025)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
par: Yuhan Xie, et autres
Publié: (2025)

Reversal of the concreteness effect can be detected in the natural speech of older adults with amnestic, but not non‐amnestic, mild cognitive impairment
par: Luwen Cao, et autres
Publié: (2024)

Commentary on “It is time to share Alzheimer biomarker results in dementia with Lewy bodies”
par: John T. O'Brien
Publié: (2025)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
par: Darren M. Lipnicki, et autres
Publié: (2026)

Hospitalization outcomes among older adults living undiagnosed or unaware of dementia
par: Halima Amjad, et autres
Publié: (2025)

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
par: Zheng Long Lee, et autres
Publié: (2026)

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
par: Russell Banks, et autres
Publié: (2024)

Vision and hearing difficulty and effects of cognitive training in older adults
par: Alison R. Huang, et autres
Publié: (2024)

Preclinical dementia rating scores are associated with plasma phosphorylated tau‐217
par: Qi Huang, et autres
Publié: (2025)

Exploring cognitive progression subtypes in the Framingham Heart Study
par: Huitong Ding, et autres
Publié: (2024)

Modeling contributions of cognition and apathy to functional impairment in younger‐onset dementia
par: Samuel L. Warren, et autres
Publié: (2026)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
par: Soheil Mohammadi, et autres
Publié: (2025)

Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry‐based proteomics
par: Marijke E. Stokkel, et autres
Publié: (2026)

Underlying brain and genetic mechanisms linking historic phone use patterns, visual decline, and dementia risk in middle‐aged and older adults
par: Xiayin Zhang, et autres
Publié: (2025)

Task‐evoked pupillary responses as potential biomarkers of mild cognitive impairment
par: Julius Opwonya, et autres
Publié: (2024)

Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990–2021: A systematic analysis for the Global Burden of Disease study 2021
par: Fang Wang, et autres
Publié: (2025)

Brief webcam test of hand movements predicts episodic memory, executive function, and working memory in a community sample of cognitively asymptomatic older adults
par: Renjie Li, et autres
Publié: (2024)

Cross‐sectional study of plasma phosphorylated tau 217 in persons without dementia
par: Toni T. Saari, et autres
Publié: (2025)

Artificial intelligence detection of cognitive impairment in older adults during walking
par: Shuichi P. Obuchi, et autres
Publié: (2024)

Motor, not cognitive, performance relates to amyloid status in normal older adults
par: Amanda Cook Maher, et autres
Publié: (2026)

Epigenetic age acceleration and cognitive performance over time in older adults
par: Aung Zaw Zaw Phyo, et autres
Publié: (2024)

Circulating sphingolipids in relation to cognitive decline and incident dementia: The Cardiovascular Health Study
par: Kristine F. Moseholm, et autres
Publié: (2024)

Sex variation in the relationship between APOE ε4, cognitive decline, and dementia
par: Eleanor M. Kerr, et autres
Publié: (2025)

Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
par: Emily K. Schworer, et autres
Publié: (2024)

Tracking clinical and neuroimaging progression of Alzheimer's disease by longitudinal trajectories of plasma biomarkers
par: Frederikke Kragh Clemmensen, et autres
Publié: (2026)

Subjective memory concerns and AD/ADRD plasma biomarker associations in HABS‐HD
par: Kelsey R. Thomas, et autres
Publié: (2026)

Ethics of disclosure of onset‐predictive biomarker test results for genetic frontotemporal dementia in the research context
par: Charlotte H. Graafland, et autres
Publié: (2025)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
par: Lars Frings, et autres
Publié: (2025)